Moi Lin Ling
-
- Antibiotic Use and Resistance 10
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 14
- General Dentistry top 1%
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 13
- Infection Control in Healthcare 11
-
- Infection Control and Ventilation 10
-
- COVID-19 and Mental Health 8
-
- COVID-19 and healthcare impacts 8
-
- COVID-19 epidemiological studies 8
- Co-authors
- Dale FisherBrenda AngPaul Anantharajah TambyahJames S. MoltonBan Hock TanIndumathi VenkatachalamKwee Yuen TanXiang Ying Jean Sim
In The Last Decade
Moi Lin Ling
64 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 147
- Applied Microbiology and Biotechnology 255
- Molecular Medicine 417
- General Dentistry 143
- Infectious Diseases 576
- Critical Care and Intensive Care Medicine 143
Countries citing papers authored by Moi Lin Ling
This map shows the geographic impact of Moi Lin Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moi Lin Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moi Lin Ling more than expected).
Fields of papers citing papers by Moi Lin Ling
This network shows the impact of papers produced by Moi Lin Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moi Lin Ling. The network helps show where Moi Lin Ling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Moi Lin Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 10 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 65 | |
| 8 | 2020 | 137 | |
| 9 | 2020 | 39 | |
| 10 | 2019 | 8 | |
| 11 | 2019 | 80 | |
| 12 | 2019 | 11 | |
| 13 | 2018 | 0 | |
| 14 | 2015 | 24 | |
| 15 | 2015 | 27 | |
| 16 | 2015 | 86 | |
| 17 | 2011 | 35 | |
| 18 | 2008 | 1 | |
| 19 | 2008 | 29 | |
| 20 | 2000 | 10 |
About Moi Lin Ling
Moi Lin Ling is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Endocrinology, having authored 68 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (14 papers), Antimicrobial Resistance in Staphylococcus (13 papers), Infection Control in Healthcare (11 papers), Infection Control and Ventilation (10 papers), Antibiotic Use and Resistance (10 papers), COVID-19 and Mental Health (8 papers), COVID-19 and healthcare impacts (8 papers) and COVID-19 epidemiological studies (8 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (255 citations), Molecular Medicine (417 citations) and General Dentistry (143 citations). Moi Lin Ling has collaborated with scholars based in Singapore, Thailand and Australia. Frequent co-authors include Dale Fisher, Brenda Ang, Paul Anantharajah Tambyah, James S. Molton, Ban Hock Tan, Indumathi Venkatachalam, Kwee Yuen Tan, Xiang Ying Jean Sim, Li Yang Hsu and Liang En Wee. Their work appears in journals such as American Journal of Infection Control, Antimicrobial Resistance and Infection Control, Infection Control and Hospital Epidemiology, Journal of Hospital Infection and Infection Disease & Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.